[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350589-105":59,"doc-detail-350589-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tumor-heterogeneity-development-mechanisms-and-therapeutic-implications","Tumor heterogeneity: development, mechanisms, and therapeutic implications","","Tumor heterogeneity is a core hallmark of cancer that accelerates progression, metastasis, and resistance to therapy. The review attributes this diversity to persistent genomic instability, dynamic clonal evolution, and plasticity of cancer stem cells, further shaped by complex interactions within the tumor microenvironment. Residual resistant subclones after conventional treatment often drive relapse. Single-cell multiomics, spatial transcriptomics, and liquid biopsy enable multidimensional analysis across molecular, cellular, spatial, and temporal scales, guiding precision therapeutic strategies and future dynamic monitoring.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-heterogeneity-development-mechanisms-and-therapeutic-implications/350589/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-heterogeneity-development-mechanisms-and-therapeutic-implications/350589.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What drives tumor heterogeneity and why does it matter?","Question",{"text":113,"@type":114},"Tumor heterogeneity arises from genomic instability, clonal evolution, and cancer stem cell plasticity, amplified by interactions in the tumor microenvironment. It worsens metastasis and treatment resistance, increasing the risk of relapse.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is intratumor heterogeneity (ITH) characterized?",{"text":118,"@type":114},"ITH includes spatial and temporal heterogeneity. Spatial heterogeneity reflects genetic differences across tumor regions or between primary and metastatic lesions, while temporal heterogeneity reflects genetic changes occurring over time.",{"name":120,"@type":111,"acceptedAnswer":121},"Which technologies help dissect tumor heterogeneity across scales?",{"text":122,"@type":114},"Single-cell multiomics, spatial transcriptomics, and liquid biopsy allow comprehensive, multidimensional dissection across molecular, cellular, spatial, and temporal dimensions, revealing real-time evolution dynamics.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350589,1790151351,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nREVIEW ARTICLE OPEN  \nTumor heterogeneity: development, mechanisms, and therapeutic implications  \nJianhong Zhang 1, Heng Li 1, Shuo Ru2,3, Hui Feng1, Junsong Guo4, Danlei Sun 1, Tingxiu Xiang5 ✉, Daqian Xu2,3 ✉ and Yang Luo 1,6 ✉  \n\n|  | Tumor heterogeneity is a fundamental hallmark of cancer that drives progression, metastasis and therapeutic resistance. This diversity originates from persistent genomic instability, dynamic clonal evolution, and cancer stem cell plasticity, which are further ampliﬁed through complex crosstalk within the tumor microenvironment. While conventional therapies effectively eliminate certain tumor cell populations, residual resistant subclones frequently lead to disease relapse. Recent breakthroughs in single-cell multiomics, spatial transcriptomics, and liquid biopsy now enable a comprehensive, multidimensional dissection of tumor heterogeneity across molecular, cellular, spatial, and temporal scales. These approaches reveal real-time dynamics of tumor evolution, providing new opportunities for therapeutic intervention. This review synthesizes key advances in understanding tumor heterogeneity: from its cellular origins and molecular mechanisms to its multidimensional manifestation in the tumor microenvironment and from metastatic heterogeneity to the fundamental causes of treatment resistance. We critically examine how these insights are informing novel therapeutic paradigms—including targeting clonal cooperative networks, modulating epigenetic plasticity andreprogramming metabolic adaptations. Finally, we outline future pathways toward precision medicine through the integration of multi-omics data and dynamic monitoring technologies. Ultimately, overcoming tumor heterogeneity necessitates |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| reconceptualizing cancer not as a static collection of cells but as a dynamically evolving ecosystem. |  |  |\n|  | Signal Transduction and Targeted Therapy (2026)11:271 ; [https://doi.org/10.1038/s41392-026-02749-7](https://doi.org/10.1038/s41392-026-02749-7) |  |\n|  |  |  |\n\nINTRODUCTION  \nThe molecular nature of cancer is highly variable, with cellular differences not only between patients but also within the same patient and within the same tumor. Detailed mapping of genetic, epigenetic, and transcriptional alterations across diverse tumors can reveal the full extent of this variation.1,2 As a highly dynamic disease characterized by plasticity, cancer evolves rapidly, becoming increasingly heterogeneous at the genetic, phenotypic and pathological levels.3 Heterogeneity thus represents one of the key features of most tumors, reﬂecting the diverse subpopulations of tumor cells with distinct characteristics and posing a signiﬁcant challenge in cancer ecosystems.4  \nPrevious studies identiﬁed distinct subpopulations of malignant cells within a single tumor, suggesting that carcinogenesis follows a complex and divergent evolution of genetic mutations.5 Nonetheless, this concept has evolved signiﬁcantly with advancements in cancer research over time.6 Recent ﬁndings suggest that tumor heterogeneity arises from the clonal expansion of genetically altered cells interacting with the tumor microenvironment (TME), giving rise to genetic and epigenetic diversity shaped by both Darwinian and non-Darwinian evolutionary trajectories.7 Accordingly, tumor heterogeneity is currently deﬁned as the differences between cancer cells within a single tumor, between  \nprimary and metastatic tumors, or even between tumors of the same type in different patients.7 It arises primarily from cancer cell-intrinsic genetic variation, as well as variations in cellular properties and intrinsic plasticity.8 These differences contribute to ","cbCaitzagi4jOY2b","https://ap.wps.com/l/cbCaitzagi4jOY2b","pdf",4661492,29,"English","# Introduction\n## Tumor heterogeneity as a cancer hallmark\n## Forms of heterogeneity: ITH and spatiotemporal dynamics\n## Clonal and microenvironmental origins\n# Future directions in precision therapy","[{\"question\":\"What drives tumor heterogeneity and why does it matter?\",\"answer\":\"Tumor heterogeneity arises from genomic instability, clonal evolution, and cancer stem cell plasticity, amplified by interactions in the tumor microenvironment. It worsens metastasis and treatment resistance, increasing the risk of relapse.\"},{\"question\":\"How is intratumor heterogeneity (ITH) characterized?\",\"answer\":\"ITH includes spatial and temporal heterogeneity. Spatial heterogeneity reflects genetic differences across tumor regions or between primary and metastatic lesions, while temporal heterogeneity reflects genetic changes occurring over time.\"},{\"question\":\"Which technologies help dissect tumor heterogeneity across scales?\",\"answer\":\"Single-cell multiomics, spatial transcriptomics, and liquid biopsy allow comprehensive, multidimensional dissection across molecular, cellular, spatial, and temporal dimensions, revealing real-time evolution dynamics.\"}]","Tumor heterogeneity: development, mechanisms, and therapeutic implications | PDF",1790089743,73,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9568870fe36740dd3d40c1926d298ac5.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6c3e484efae4a6359b82b4427f11d7b.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20553398140aece5bf2af013908c19bf.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a621fd3dc670cdf4f3d732bd24d4e85e.webp",980,1301]